DOX AMDOCS LIMITED
Research report · from SEC EDGAR
executive summary
AMDOCS LIMITED (DOX). Revenue is $5.00B (+2.4% y/y) at a 10% net margin. It is profitable. Our health score is C (58/100). No major red flags on file. Held by 2 tracked funds. It funds itself; low dilution risk.
Revenue (TTM)
$5.00B
+2.4% y/y
✓ No major red flags from our filing-based checks.
who's buying
Insider buys / sells
0 / 1
Cash & ST investments
$346.1M
Operating cash flow
$724.4M
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated today by stocktools.ai.